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ABSTRACT
Although prior falls are a well-established predictor of future fracture, there is currently limited evidence regarding the speciﬁc value
of falls history in fracture risk assessment relative to that of other clinical risk factors and bone mineral density (BMD) measurement.
We therefore investigated, across the three Osteoporotic Fractures in Men (MrOS) Study cohorts, whether past falls predicted future
fracture independently of FRAX andwhether these associations variedwith age and follow-up time. Elderlymenwere recruited from
MrOS Sweden, Hong Kong, and USA. Baseline data included falls history (over the preceding 12 months), clinical risk factors, BMD at
femoral neck, and calculated FRAX probabilities. An extension of Poisson regression was used to investigate the associations
between falls, FRAX probability, and incident fracture, adjusting for age, time since baseline, and cohort in base models; further
models were used to investigate interactions with age and follow-up time. Random-effects meta-analysis was used to synthesize the
individual country associations. Information on falls and FRAX probability was available for 4365 men in USA (mean age 73.5 years;
mean follow-up 10.8 years), 1823 men in Sweden (mean age 75.4 years; mean follow-up 8.7 years), and 1669 men in Hong Kong
(mean age 72.4 years; mean follow-up 9.8 years). Rates of past falls were similar at 20%, 16%, and 15%, respectively. Across all cohorts,
past falls predicted incident fracture at any site (hazard ratio [HR]¼ 1.69; 95% conﬁdence interval [CI] 1.49, 1.90), major osteoporotic
fracture (MOF) (HR¼ 1.56; 95% CI 1.33, 1.83), and hip fracture (HR¼ 1.61; 95% CI 1.27, 2.05). Relationships between past falls and
incident fracture remained robust after adjustment for FRAX probability: adjusted HR (95% CI) any fracture: 1.63 (1.45, 1.83); MOF:
1.51 (1.32, 1.73); and hip: 1.54 (1.21, 1.95). In conclusion, past falls predicted incident fracture independently of FRAX probability,
conﬁrming the potential value of falls history in fracture risk assessment. © 2017 The Authors. Journal of Bone and Mineral Research
Published by Wiley Periodicals Inc.
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Introduction
Although low bone mineral density is a major risk factor forfragility fracture, the majority of such low-trauma fracture
events occur as a result of a fall from standing height or less.(1)
Conversely, the number of falls is much greater than the number
of consequent fractures with only 5% to 10% of falls in older
adults leading to skeletal injury.(1) Interventions aimed at
reducing falls have usually been unsuccessful at reducing
fractures,(2,3) probably partly as a consequence of the low falls to
injury ratio. Notwithstanding, prior falls have been found to be
a risk factor for future fracture in a number of cohorts.(4) With
the advent of the FRAX fracture risk assessment tool, evaluation
of an individual’s probability of sustaining a hip or major
osteoporotic fracture over a 10-year time period is now readily
undertaken using a small number of easily ascertainable clinical
risk factors and BMD if available.(5) FRAX is the most widely used
fracture risk assessment tool, incorporated into the majority of
assessment guidelines worldwide(6) but, unlike other tools such
as QFracture or the GARVAN calculator,(7–9) does not include falls
as a speciﬁc input risk factor(4,5) because of the inconsistent data
across the 12 derivation and 11 validation cohorts.(10) In order for
prior falls to be useful in the current context of risk assessment,
the associated fracture risk must ideally be independent of
FRAX probability and/or BMD. Having demonstrated that the
risk of future falls associated with past falls is partly captured
by FRAX,(11) we undertook to investigate, across the three
Osteoporotic Fractures in Men (MrOS) Study cohorts, whether a
history of past falls (in the previous 12 months) independently
predicted future fractures and whether the predictive value
varied with follow-up time or age.
Subjects and Methods
Participants
Details of the Osteoporotic Fractures in Men (MrOS) Interna-
tional Study have been published previously,(12,13) but brieﬂy,
MrOS is a multicenter study of community-dwelling men aged
65 years or older from three countries, recruited and evaluated
using similar criteria. To be eligible for the study, subjects
had to be able to walk without aid. In the MrOS Hong Kong
Study, 2000 Chinese men, aged 65 to 92 years, were enrolled
between August 2001 and February 2003.(14) All were Hong
Kong residents of Asian ethnicity. Stratiﬁed sampling was
adopted to ensure that 33% of subjects were included in each
of the following age groups: 65 to 69, 70 to 74, and 75 years.
Recruitment notices were placed in housing estates and
community centers for the elderly. In the MrOS Sweden
Study, 3014 men, aged 69 to 81 years, were enrolled between
October 2001 and December 2004.(11,15) The cohort comprised
men from the cities of Malmo, Gothenburg, and Uppsala,
identiﬁed and recruited using national population registers.
More than 99% were of white ethnicity. The participation rate in
the MrOs Sweden Study was 45%. In the MrOS United States
Study, 5995 men, aged 65 to 100 years, were enrolled at six sites
between March 2000 and April 2002.(16,17) Each US clinical site
designed and customized strategies to enhance recruitment of
its population. Common strategies included mailings from the
Department ofMotor Vehicles, voter registration and participant
databases, common senior newspaper features and advertise-
ment, and targeted presentations. Self-deﬁned racial/ethnic
ancestry was ascertained through questionnaires at baseline.
Exposure variables
At baseline, height (centimeters) and weight (kilograms) were
measured, and body mass index (BMI) was calculated as
kilograms per square meter. The international MrOS question-
naire(16) was administered at baseline to collect information
about current smoking, number and type of medications,
fracture history, family history of hip fracture, past medical
history (rheumatoid arthritis), and high consumption of alcohol
(3 or more glasses of alcohol-containing drinks per day),
calculated from the reported frequency and amount of alcohol
use. Previous fracture at baseline was documented as all
fractures after the age of 50 years, regardless of trauma. For
glucocorticoid exposure, this was documented in MrOs as use at
least 3 times per week in the month preceding the baseline
assessment. Apart from rheumatoid arthritis, there was no
information on secondary causes of osteoporosis, and the input
variable for FRAX probability calculation was set to no for all
men. Self-reported falls during the 12 months preceding the
baseline were recorded by questionnaire (past falls). Areal bone
mineral density (aBMD) was measured at the femoral neck (FN)
using Hologic QDR 4500 A or W (Hologic, Bedford, MA, USA) or
Lunar Prodigy (GE Lunar Corp., Madison, WI, USA) depending on
the center, with cross calibration of instruments. A T-score was
calculated using NHANES young women as a reference value.(18)
Ten-year probability of fracture (FRAX major osteoporotic
fracture [hip, humerus, vertebral, or forearm sites]) was
calculated using clinical risk factors described above with and
without femoral neck BMD entered into country-speciﬁc FRAX
models. Because the gradients of risk for incident falls were
similar with either model, results for the models including
femoral neck BMD are presented.
Fracture and death outcomes
Hong Kong(19)
Incident fractures were captured via subject follow-up through
phone call or visit to the research center. All fracture sites (hip,
wrist, skull/face, ribs, shoulder, arm, wrist, vertebra, tibia, ﬁbula,
foot, metatarsal toes, hand, ﬁngers, and pelvis) were recorded.
Pathological fractures were excluded. All incident fractures
reported by participants were then conﬁrmed by radiograph or
medical record. Deaths were veriﬁed by death certiﬁcates.
Sweden(20)
Central registers covering all Swedish citizens were used to
identify the subjects and the time of death for all subjects who
died during the study, and these analyses were performed after
the time of fracture validation. At the time of fracture evaluation,
the computerized X-ray archives in Malmo, Gothenberg, and
Uppsala were searched for new fractures occurring after the
baseline visit using the unique personal registration number
allocated to every Swedish citizen. All additional fractures
reported by the study subject after the baseline visit were
conﬁrmed by physician review of radiology reports. Fractures
reported by the study subject but not possible to conﬁrm by
radiographic report were not included.
US(16)
If a participant reported a fracture, study staff conducted a
follow-up telephone interview to determine the date and time
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the fracture occurred, a description of how the fracture occurred,
the type of trauma that resulted in the fracture, the participant’s
location and activities at the time of the fracture, symptoms just
before or coincident with the fracture, and source of medical
care for the fracture. All reported fractures were veriﬁed by a
physician adjudicator through medical records obtained from
the participant’s physician. The Clinical Outcomes Committee
adjudicated any uncertainties regarding the presence of a
fracture. Deaths were veriﬁed through state death certiﬁcates.
Statistical methods
To compare the performance of FRAX probability with that of a
history of past falls, a dichotomous variable was created such
that the percentage of men who had a high fracture risk was
similar to the percentage who had previously fallen (15% for HK,
16% for Sweden, and 20% for US). Thus, 15%, 16%, and 20%
men, respectively, had a FRAX probability of major osteoporotic
fracture, calculated with BMD, above 9.5%, 15.8%, and 10.3%
and the dichotomized FRAX score was therefore classiﬁed
as high or low risk. Fracture outcomes considered included:
any, osteoporotic (deﬁned according to Kanis and colleagues(21)
as clinical vertebral, ribs, pelvis, humerus, clavicle, scapula,
sternum, hip, other femoral fractures, tibia, ﬁbula, distal forearm/
wrist), major osteoporotic (MOF; hip, clinical vertebral, humerus,
and wrist/forearm), osteoporotic fracture without hip fracture
(clinical vertebral, humerus, andwrist), clinical vertebral, and hip.
An extension of Poisson regression models(22)was used to study
the association between FRAX, other risk variables, and the
future risk of fracture. All associations were adjusted for age and
time since baseline. In contrast to logistic regression, the Poisson
regression uses the length of each individual’s follow-up period,
and the hazard function is assumed to be exp(b0þb1 current
time from baselineþb2 current ageþb3 variable of inter-
est). The observation period of each participant was divided into
intervals of 1 month. One fracture per person, and time to the
ﬁrst fracture, were counted, and time at risk was censored at the
time of ﬁrst fracture, migration, or death. Thus, we investigated
the predictive value of prior falls, FRAX (including each
individual constituent risk factor), and BMD as individual risk
factors, and then in multivariable models to investigate the
value of falls independent of FRAX or BMD, and FRAX
independent of falls. In further analyses, we explored inter-
actions with age and time since baseline, in which age and time
were used as continuous variables and examples given at
speciﬁc ages and times. Additionally, we stratiﬁed the analyses
by femoral neck BMD T-score above or below –2.5. The
association between predictive factors and risk of fracture are
described as a hazard ratio (HR) or gradient of risk (GR¼HR per 1
standard deviation change in predictor in the direction of
increased risk). In addition, we explored the associations
between falls and fracture by number of falls reported at
baseline (1 versus multiple). Two-sided p values were used for all
analyses, and p< 0.05was considered to be signiﬁcant. Analyses
were undertaken separately within each cohort and then
the b-coefﬁcients from each cohort were weighted according
to the variance and merged to determine the weighted mean of
the coefﬁcient and its standard deviation (random-effects
meta-analysis). The risk ratios are then given by e(weighted mean
coefﬁcient). Although there are numerous caveats with the use of
receiver operator curve (ROC) models in this context,(23) we
additionally present area under the curve (AUC) values for the
predictive models in the Supplemental Tables.
Results
Characteristics of participants
The study cohort consisted of 7857 men who had information
on falls, BMD, and FRAX risk factors: 4365 men in the US
(mean age 73.5 years; mean follow-up 10.8 years); 1823 men in
Sweden (mean age 75.4 years; mean follow-up 8.7 years); and
1669 men in Hong Kong (mean age 72.4 years; mean follow-up
9.8 years). Table 1 summarizes the baseline characteristics of the
individuals by country cohort. Rates of past falls were similar at
20%, 16%, and 15% respectively. Rates of previous fracture were
higher in Sweden (33%) than in the US (22%) and Hong Kong
(13%). Consistent with the known country-speciﬁc epidemiol-
ogy of fracture, the highest mean FRAX probability was
observed in Sweden (11.4% probability of major osteoporotic
Table 1. Baseline Characteristics of MrOS Participants by
Country Cohort
Hong
Kong Sweden USA
Proportion of whole cohort 83% 61% 73%
No. of participants 1669 1823 4365
Person-years 16,423 15,878 47,044
Age (years), mean (range) 72.4
(65–91)
75.4
(70–81)
73.5
(64–99)
Body mass index 23.5 3.2 26.3 3.6 27.42 3.9
Previous fracture 13% 33% 22%
Family history hip fracture 5% 13% 17%
Smoker 12% 8% 3%
Steroid 1% 2% 2%
Rheumatoid arthritis 1% 1% 5%
Excess alcohol 1% 3% 4%
BMD FN T-score –1.4 0.9 –0.9 1.0 –0.6 1.1
Fall at baseline 15% 16% 20%
No. falls at baseline
0: 0 times 1426
(85%)
1538
(84%)
3478
(80%)
1: 1 time 192
(12%)
162 (9%) 519 (12%)
2: 2–3 times 42 (3%) 85 (5%) 305 (7%)
3: 4–5 times 6 (0.4%) 14 (0.8%) 41 (0.9%)
4: 6þ times 3 (0.2%) 13 (0.7%) 22 (0.5%)
FRAX MOF without BMD
(mean SD)
6.9 2.9 13.5 6.2 9.2 5.0
FRAX hip without BMD
(mean SD)
3.4 2.6 7.5 5.5 3.7 4.0
FRAX MOF with BMD
(mean SD)
6.7 3.3 11.4 6.8 7.9 4.8
FRAX hip with BMD
(mean SD)
3.1 2.7 5.6 6.1 2.5 3.6
High FRAX (ost with BMD) 15% 16% 20%
Threshold for high FRAX (%) 9.50 14.00 10.30
FU (hip fx: mean (SD), years) 9.8 (2.9) 8.7 (2.8) 10.8 (3.8)
Any fx 11% 23% 19%
Osteoporotic fx 9% 19% 14%
MOF fx 7% 16% 10%
Hip fx 3% 7% 4%
BMD¼bone mineral density; FN¼ femoral neck; Fx¼ fracture; Ost¼
osteoporotic; MOF¼major osteoporotic fracture.
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fracture, calculated with BMD), followed by the US (7.9%) and
Hong Kong (6.7%).
Past falls, FRAX probability, and risk of incident fracture
Table 2 summarizes the relationships between past falls or
high FRAX probability at baseline and incident fractures.
Supplemental Table S1 additionally presents the predictive
value of the individual FRAX risk factors and of falls adjusted for
each of these variables. Across all cohorts, past falls predicted
any incident fracture (HR¼ 1.69; 95% CI 1.49, 1.90), major
osteoporotic fracture (HR¼ 1.56; 95% CI 1.33, 1.83), and hip
fracture (HR¼ 1.61; 95% CI 1.27, 2.05). Similar relationships
were found for osteoporotic fracture and major osteoporotic
fracture without hip fracture, summarized in Table 2. The
predictive value of past falls was present within each individual
cohort apart from when hip fracture was the outcome, where
for Sweden and Hong Kong, the 95% CI included unity. The
magnitudes of the gradients of risk were similar in Sweden and
US cohorts, and marginally higher in the Hong Kong cohort,
albeit with substantially overlapping conﬁdence intervals, and
there was thus no statistically signiﬁcant interaction between
falls and center. For illustrative purposes, Supplemental Table S2
demonstrates the fracture incidence amongst the four groups
deﬁned by high versus low FRAX probability and falls yes/no;
the hazard ratio for major osteoporotic fracture is also given for
the remaining three groups relative to the low FRAX probability
and no falls groups.
The hazard ratio associated with multiple falls tended to be
marginally greater than that associated with a single fall, for
example, HR for 1 fall for MOF¼ 1.56 (95% CI 1.33, 1.83) and HR
for 2 falls¼ 2.00 (95% CI 1.35, 2.98). High FRAX probability
of major osteoporotic fracture, calculated with BMD, was
predictive of all fracture outcomes, with the magnitude of the
HR greater than for the equivalent falls-fracture relationships
(summarized in Table 2). Thus, across all cohorts, high FRAX
predicted any incident fracture (HR¼ 2.00; 95% CI 1.73, 2.31),
major osteoporotic fracture (HR¼ 2.35; 95% CI 1.87, 2.94), and
hip fracture (HR¼ 2.93; 95% CI 1.75, 4.88).
Independent predictive value of falls, FRAX probability,
and BMD
The relationships between past falls and incident fracture
remained robust after adjustment for high FRAX probability
(MOF): adjusted HR (95% CI) any fracture: 1.63 (1.45, 1.83); MOF:
1.51 (1.29, 1.77); and hip: 1.54 (1.21, 1.95), and for BMD (Table 3).
Indeed, the hazard ratios and 95% CI were very little altered by
adjustment for high FRAX probability or BMD. Similarly, the
gradient of risk for fracture outcomeswith high FRAX probability
were little altered by adjustment for the presence of reported
past falls at baseline (Table 3): adjusted HR (95% CI) any fracture:
1.96 (1.69, 2.27); MOF: 2.30 (1.84, 2.88); and hip: 2.86 (1.73, 4.75).
The associations with the outcomes of clinical vertebral fracture
and osteoporotic fracture without hip fracture (OWH) are
documented in Supplemental Table S3, demonstrating that
Table 2. Relationships Between Past Falls, FRAX, and Risk of New Fracture
Any fx Ost fx MOF Hip fx
Falls at baseline HK 1.93 (1.38, 2.70) 1.83 (1.25, 2.68) 2.01 (1.32, 3.05) 1.71 (0.92, 3.21)
SW 1.61 (1.27, 2.03) 1.50 (1.16, 1.94) 1.50 (1.13, 1.98) 1.34 (0.85, 2.09)
US 1.67 (1.43, 1.94) 1.54 (1.29, 1.84) 1.50 (1.21, 1.86) 1.74 (1.27, 2.38)
Total 1.69 (1.49, 1.90) 1.56 (1.36, 1.79) 1.56 (1.33, 1.83) 1.61 (1.27, 2.05)
High FRAX (MOF with BMD) HK 2.45 (1.78, 3.38) 3.04 (2.14, 4.32) 3.20 (2.17, 4.72) 5.27 (3.07, 9.05)
SW 1.76 (1.40, 2.21) 1.83 (1.43, 2.34) 1.98 (1.52, 2.57) 1.82 (1.21, 2.74)
US 2.01 (1.74, 2.33) 2.13 (1.80, 2.52) 2.29 (1.87, 2.79) 2.84 (2.11, 3.81)
Total 2.00 (1.73, 2.31) 2.21 (1.75, 2.79) 2.35 (1.87, 2.94) 2.93 (1.75, 4.88)
Fx¼ fracture; Ost¼ osteoporotic; MOF¼major osteoporotic fracture; HK¼Hong Kong; SW¼ Sweden; US¼United States; BMD¼bonemineral density.
Data are hazard ratios (95% CI) adjusted for age and time since baseline.
Table 3. Past Falls Adjusted for FRAX Probability and FRAX Probability Adjusted for Past Falls, as Predictors of Incidence Fracture
Any fx Ost fx MOF Hip fx
Falls at baseline adjusted for FRAX HK 1.87 (1.34, 2.62) 1.76 (1.20, 2.59) 1.94 (1.28, 2.96) 1.47 (0.78, 2.78)
SW 1.56 (1.23, 1.97) 1.45 (1.12, 1.88) 1.44 (1.09, 1.90) 1.29 (0.82, 2.01)
US 1.61 (1.39, 1.88) 1.49 (1.25, 1.78) 1.45 (1.17, 1.80) 1.69 (1.23, 2.31)
Total 1.63 (1.45, 1.83) 1.51 (1.32, 1.73) 1.51 (1.29, 1.77) 1.54 (1.21, 1.95)
Falls at baseline adjusted for femoral neck BMD HK 1.92 (1.38, 2.69) 1.82 (1.24, 2.67) 2.00 (1.31, 3.03) 1.68 (0.89, 3.14)
SW 1.64 (1.29, 2.07) 1.52 (1.17, 1.96) 1.50 (1.14, 1.99) 1.31 (0.84, 2.05)
US 1.69 (1.45, 1.96) 1.56 (1.31, 1.86) 1.54 (1.24, 1.90) 1.82 (1.33, 2.48)
Total 1.71 (1.51, 1.92) 1.58 (1.38, 1.81) 1.58 (1.35, 1.85) 1.64 (1.29, 2.08)
High FRAX (MOF with BMD) adjusted for falls HK 2.41 (1.74, 3.33) 3.00 (2.11, 4.26) 3.15 (2.13, 4.65) 5.13 (2.98, 8.85)
SW 1.72 (1.36, 2.16) 1.80 (1.41, 2.30) 1.94 (1.49, 2.52) 1.79 (1.19, 2.71)
US 1.97 (1.70, 2.28) 2.10 (1.78, 2.48) 2.25 (1.85, 2.75) 2.79 (2.08, 3.75)
Total 1.96 (1.69, 2.27) 2.17 (1.72, 2.74) 2.30 (1.84, 2.88) 2.86 (1.73, 4.75)
Fx¼ fracture; Ost¼ osteoporotic; MOF¼major osteoporotic fracture; HK¼Hong Kong; SW¼ Sweden; US¼United States.
Data are hazard ratios (95% CI) adjusted for age and time since baseline.
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both prior falls and FRAX probability were predictive of both
outcomes. Supplemental Table S4 demonstrates the predictive
value of these exposures when femoral neck BMD at baseline is
dichotomized above/below T¼ –2.5. For illustrative purposes,
the AUC values for the different predictionmodels are presented
in Supplemental Table S5.
Interactions between past falls, age, follow-up time, and
risk of incident fracture
In both Sweden and the US, there was a tendency for the
hazard ratio for fracture associated with past falls to reduce
with increasing follow-up time (p interaction¼ 0.12 and 0.15,
respectively). In contrast, no decline with time was observed in
the Hong Kong cohort (p> 0.30). The interaction between
past falls and follow-up time became close to statistical
signiﬁcance (p¼ 0.059) when all three cohorts were combined
(Fig. 1). There was no evidence of an interaction with age.
No interactions for either follow-up time or age with high
FRAX probability were observed.
Discussion
In this large combined population cohort of older men, we have
demonstrated that previous falls and high FRAX probability
independently predict the risk of future fracture. These ﬁndings
clearly conﬁrm the value of falls in fracture risk assessment and
demonstrate that consideration of past falls yields information
over and above that captured by the FRAX algorithm.
The predictive value of past falls for future fracture is well
established,(24) but the present study, to our knowledge,
provides the ﬁrst evidence from a large population-based
cohort that this risk is independent of that captured by FRAX
with or without BMD. It complements our previous ﬁndings,
from theMrOS Sweden cohort, of similar predictive value of past
falls and FRAX probability for future falls,(11) extending this to the
key musculoskeletal consequence, namely fracture. Similar to
the present study, although risk factors for falls and fracture
overlap substantially, and many of which are captured in the
FRAX tool, the magnitude of the predictive value of past falls or
high FRAX probability was not materially altered by mutual
adjustment, indicating that falls history is likely to inform risk not
captured by FRAX probability. Interestingly, prior falls predicted
incident clinical vertebral fracture as well as the other fracture
types. Although vertebral fractures in women have largely been
thought to result from actions such as lifting, rather than from
falls,(25) data from the US MrOS cohort suggested that falls were
common antecedents of clinical presentation with a vertebral
fracture amongst older men.(26)
These ﬁndings support the notion that consideration of falls
history is likely to add usefully to risk assessment based on the
FRAX tool and as such will be of relevance to a large number of
guidelines globally.(6) Although falls have been incorporated
into risk calculators derived from single cohorts in which these
outcomes have been recorded,(7–9,27,28) the lack of standardized
documentation of falls events across the 23 cohorts used in the
development and validation of the FRAX tool has meant that the
use of prior falls as a clinical risk factor was not possible.(4) A
further consideration is that FRAX input variables were selected
on the basis of at least partial independence of BMD and of
constituting a risk amenable to pharmacological therapeutic
intervention. Although our present ﬁndings strongly support
the ﬁrst of these criteria, there is still limited evidence that
interventions to reduce falls will also reduce fractures(2–4,29–34) or
that falls risk is amenable to intervention with pharmacological
agents such as bisphosphonates.(4,5) In one study, baseline risk
of falling was not associated with differences in anti-fracture
efﬁcacy of clodronate,(35) suggesting efﬁcacy in fallers and non-
fallers alike. In contrast, in a trial of risedronate in elderly women
selected partly on the basis of high falls risk, the intervention did
not lead to statistically signiﬁcant reductions in fractures.(36)
Recognizing the limitations of falls data in the current
FRAX cohorts, a report of an International Society for Clinical
Densitometry/International Osteoporosis Foundation Task
Force recommended that FRAX probability may be modiﬁed
to account for a history of prior falls, with the output inﬂated by
30% (multiplied by 1.3) for each past fall (for up to 5 falls).(4) This
recommendation is based on the univariate hazard ratio (95% CI
1.1, 1.5) for incident hip fracture associated with a past fall,
derived from the Study of Osteoporotic Fractures.(37) Notably, in
this cohort the fall-fracture relationship became statistically
nonsigniﬁcant after adjustment for poor health and markers of
poor mobility; furthermore, this study did not investigate the
predictive power of falls independent of other clinical risk factors
or BMD. Although the exact approach to incorporation of prior
falls into risk assessment remains to be elucidated, our ﬁndings
inform clinical care, demonstrating that prior falls indicate
increased fracture risk over and above that generated by use of
other clinical risk factors and BMD in FRAX. Notwithstanding the
inconclusive evidence relating falls interventions to fracture
reduction, falls risk should clearly be addressed as part of
the risk assessment, in addition tomeasures speciﬁcally aimed at
improving bone mineral density.
Our ﬁndings of potential time interactions for past falls and
incident fractures are intriguing and echo our previous
observation that the predictive value of past falls for incident
falls in the MrOS Sweden cohort also waned with increasing
follow-up time and was greater at younger ages.(11) Falls-related
risk factors were found to be predictive of fracture risk over a
2-year period in a recent US study, but because this investigation
did not compare the short-term relationships with those over a
longer time period, it is difﬁcult to draw ﬁrm conclusions
regarding any temporal variation in effect size with regard to
falls and follow-up.(38) Although it seems intuitively reasonable
that falls might mark out particularly unusual individuals relative
to the general population at younger ages, where falls overall
are less common, it is perhaps counterintuitive that past falls
become less predictive of incident falls with time. It is possible
Fig. 1. Interaction between past falls and follow-up time, and risk of any
incident fracture.
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that fallers tend to fracture earlier and become less mobile
and perhaps less exposed to falls risk and thus to fracture risk
with time. For the moment, however, particularly since the
association just failed to reach statistical signiﬁcance and is
inconsistent across the three cohorts, this observation remains
of interest but requires replication in other populations.
We studied three well-characterized cohorts drawn from
general populations with standardized assessments and pro-
spective recording of fractures. However, there are some
limitations that should be considered in the interpretation of
our ﬁndings.(16) First, the population studied was male and of a
modest age range (64 to 99 years), so limiting generalizability
of our ﬁndings. Second, the deﬁnition of glucocorticoid use
differed from those usually speciﬁed for incorporation into
FRAX. Third, there was no information on causes of secondary
osteoporosis, and this variable was therefore set to missing. The
effect of these considerations on our ﬁndings is uncertain but
may have led to an overall underestimation of risk by FRAX.
Finally, we did not have information on the severity of a past fall
or whether a past fall was associated with injury, so limiting our
ability to identify events potentially most likely to be associated
with a fracture outcome.
In conclusion, we have demonstrated that prior falls are a risk
factor for incident fracture, independently of FRAX probability
calculated with or without BMD. Although our ﬁndings clearly
demonstrate the value of falls history in fracture risk assessment,
further prospective studies in cohorts with wider age ranges,
other ethnicities, and, most importantly, women are now
warranted to replicate and extend these ﬁndings, ideally to
establish the potential for inclusion of falls as a modiﬁer of FRAX
probability.
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